Product Categories
| Country: | China |
|---|---|
| Tel: | 0573-87390950 |
| Mobile: | 13806705416 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Ritlecitinib Intermediates | C14H20N2O2 | 1207947-49-6 | Details |
| Bromfenac Sodium Intermediates | C15H12BrNO | 91714-41-9 | Details |
| Allisartan Isoproxil | C27H29ClN6O5 | 947331-05-7 | Details |
| Imrecoxib | C21H23NO3S | 395683-14-4 | Details |
| Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester | C16H16N4O4S | 1869118-24-0 | Details |
| Pimavanserin Intermediates | C13H20ClFN2 | 1837794-51-0 | Details |
| Ensitrelvir Intermediates | C12H10F3N3O2S | 2771355-74-7 | Details |
| Ritlecitinib Intermediates | C13H20N2.ClH | 2922238-87-5 | Details |
| (2-Butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone | C30H40N2O5 | 141645-23-0 | Details |
| Etrasimod Intermediates | C13H14ClF3 | 957208-65-0 | Details |
| 4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide | C21H22N4O3 | 1050477-27-4 | Details |
| N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid 1,1-dimethylethyl ester | C18H20N4O4S | 1201187-44-1 | Details |
| 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid | C21H21N3O4 | 1050477-45-6 | Details |
| 3-Pyridazinecarboxylic acid, 4,6-dichloro-, lithium salt, hydrate (1:1:1) | C5H5Cl2LiN2O3 | 2245111-15-1 | Details |
| Azilsartan | C25H20N4O5 | 147403-03-0 | Details |
| Faropenem Intermediates | C5H9NaO2S | 157728-49-9 | Details |
| Ritlecitinib Tosylate | C22H27N5O4S | 2192215-81-7 | Details |
| 6-CHLORO-3-(1-METHYLETHYL)-2,4-(1H,3H)-PYRIMIDINEDIONE | C7H9ClN2O2 | 887581-47-7 | Details |
| 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid | C19H34O5 | 413624-71-2 | Details |
| Bempedoic Acid Intermediates | C11H21BrO2 | 123469-92-1 | Details |
| ritlecitinib | C15H19N5O | 1792180-81-4 | Details |
| Ritlecitinib Intermediates | C11H22N2O2 | 1227917-63-6 | Details |
| Carboplatin Intermediates | C6H8O4 | 5445-51-2 | Details |
| Mavacamten | C15H19N3O2 | 1642288-47-8 | Details |
| Heptanoic acid, 7-chloro-2,2-dimethyl-, ethyl ester | C11H21ClO2 | 2570179-39-2 | Details |
| Ritlecitinib Intermediates | C13H20N2 | 2295746-50-6 | Details |
| N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C13H19N5 | 477600-74-1 | Details |
| Upadacitinib | C17H21F3N6O2 | 2050057-56-0 | Details |
| Faropenem Intermediates | C6H10O2 | 131328-27-3 | Details |
| Ensitrelvir Intermediates | C16H15F3N6O2S | 2771355-73-6 | Details |
| Unii-na83F1sjsr | C29H40FN3O8 | 706782-28-7 | Details |
| Azilsartan Medoxomil | C30H24N4O8 | 863031-21-4 | Details |
| Bromfenac Sodium Intermediates | C15H9BrClNO | 91714-51-1 | Details |
| 7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol | C14H10F2OS | 1985607-83-7 | Details |
| Faropenem Intermediates | C5H8O3 | 87392-05-0 | Details |
| Etrasimod Arginine | C32H40F3N5O5 | 1206123-97-8 | Details |
| Avatrombopag maleate | C33H38Cl2N6O7S2 | 677007-74-8 | Details |
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate | C22H20N4O4 | 1050477-43-4 | Details |
| N-((3R,6S)-6-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C12H17N5 | 2042650-70-2 | Details |
| Aprepitant Intermediates | C20H19ClF7NO2 | 171482-05-6 | Details |
| Butylphthalide | C12H14O2 | 6066-49-5 | Details |
| (Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate | C16H14N2O4 | 1050477-39-8 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| Lobeglitazonesulfate | C24H26N4O9S2 | 763108-62-9 | Details |
| Tofacitinib Intermediates | C20H25N5 | 477600-73-0 | Details |
| Ritlecitinib Intermediates | C14H21ClN2O2 | 1207853-23-3 | Details |
| Etrasimod Arginine | C26H26F3NO3 | 1206123-37-6 | Details |
| Baloxavir Marboxil | C27H23F2N3O7S | 1985606-14-1 | Details |
| DRONEDARONE HYDROCHLORIDE | C31H44N2O5S.ClH | 141625-93-6 | Details |
| Aprepitant Intermediates | C4H8ClN3O2 | 155742-64-6 | Details |
| Bicyclol | C19H18O9 | 118159-48-1 | Details |
| Finerenone | C21H22N4O3 | 1050477-31-0 | Details |
| BempedoicAcid | C19H36O5 | 738606-46-7 | Details |
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate | C24H24N4O4 | 1050477-44-5 | Details |
| Etrasimod Intermediates | C28H30F3NO3 | 1206124-34-6 | Details |
| Deucravacitinib | C20H22N8O3 | 1609392-27-9 | Details |
| Ensitrelvir Fumarate | C26H21ClF3N9O6 | 2757470-18-9 | Details |
| Bicyclol Intermediates | C18H14O10 | 105868-34-6 | Details |
| Bicyclol Intermediates | C19H16O10 | 211996-66-6 | Details |
| Bromfenac Sodium Intermediates | C15H10BrNO | 91714-50-0 | Details |
| ABT-494 intermediate | C15H19NO4 | 1428243-24-6 | Details |
| Avatrombopag Impurity 22 | C31H38Cl2N6O3S2 | 570403-14-4 | Details |
| Faropenem Intermediates | C5H8O3 | 87392-07-2 | Details |
| Iguratimod | C17H14N2O6S | 123663-49-0 | Details |
| Tofacitinib Citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
| Azilsartan kaMedoxoMil | C30H25KN4O8 | 863031-24-7 | Details |
| (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | C16H20BrNO3 | 1428243-26-8 | Details |
| 7,8-difluorodibenzo[b,e]thiepin-11(6H)-one | C14H8F2OS | 2136287-66-4 | Details |
| Etrasimod Intermediates | C15H17NO3 | 1206124-13-1 | Details |
| (12aR)-3,4,12,12a-Tetrahydro-7-(phenylmethoxy)- 1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C17H17N3O4 | 1985607-70-2 | Details |
| Betahistine mesylate | C8H12N2.2CH4O3S | 54856-23-4 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||